David Joffe, BSPharm, CDE, Editor-in-chief, Diabetes In Control In 2003, the Treat to Target Trial study results were published. The study compared the effectiveness of a patient mediated titration schedule with both NPH and glargine, and also whether patient titration was as good as a prescriber-based titration….

Is there a difference between evidence-based medicine and evidence-based practice? Dr. Stanley Schwartz thinks so and this week we are going to share his Homerun Slides on why we need to focus on evidence-based practice in order to properly care for our patients. In 1954, Bill Haley and the Comets …

Ramsi Ajjan Richard, a 20-year-old man, is referred to the diabetes clinic with newly diagnosed diabetes (fasting glucose on two occasions more than 10 mmol/L. He has had osmotic symptons (polyuria and polydipsia) for at least 6 months and his weight has recently increased by about 14 kg….

iPatientCare, Inc. iOS/Free Basic Version The iPatientCare miEHR (mobile EHR) is a scaled-down version of iPatientCare’s full-featured EHR, and is meant to provide highly mobile healthcare providers with anywhere, anytime access to patients’ clinical records at the point-of-care. This system allows physicians to view a complete clinical summary of patients, …

This week the FDA reversed its previous decision on Avandia (see this week’s Item #1). All the hype and bad press that Dr. Steven Nissen of the Cleveland Clinic put out about the drug and its side effects led to the near demise of the drug and the TZD class …

  The Out of Sight Case® can be worn under pants, shorts or skirts, attached at the ankle, or on the thigh. The case is also perfect to toss in a backpack or purse, as the straps are detachable. The case includes a removable mesh bag that comes with or …

Type 2 diabetes patients who were less active had a 70% to 110% increased odds of coronary and cardiovascular disease and mortality compared with those who exercised at least three times a week. Researchers also found low-activity patients were 25% more likely than their more active counterparts to suffer coronary …

An analysis of 13,008 cancer patients with concurrent type 2 diabetes showed that those who took metformin attained better overall survival compared with those who took other diabetes medications. However, it is still unclear whether metformin may help modulate results in such patients, researchers wrote. First published online November 20, …

Adolescents with severe obesity and various comorbidities presented favorable safety outcomes after bariatric surgery, according to initial data from the Teen-Longitudinal Assessment of Bariatric Surgery Study. After 30 days, 19 patients (7.9%) displayed 20 major complications, and 36 patients (14.9%) displayed 47 minor complications. However, there were no deaths reported. …

The FDA has lifted the restrictions on the prescribing and use of the diabetes drug rosiglitazone on the basis of recent data that demonstrate no elevated cardiovascular risk….